Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schliemann

Showing results (331-340 of 427) with videos related to

Pageof 43
Sort By:
Oncology Letters|October 8, 2014
Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosisMichael Mohr, Christoph Schliemann, Christoph Biermann, et al.
The European Respiratory Journal|June 2, 2018
Reptin drives tumour progression and resistance to chemotherapy in nonsmall cell lung cancerJan-Henrik Mikesch, Daniela Schwammbach, Wolfgang Hartmann, et al.
Journal of Medicinal Chemistry|March 19, 2013
Anticancer therapy by tumor vessel infarction with polyethylene glycol conjugated retargeted tissue factorChristian Schwöppe, Caroline Zerbst, Max Fröhlich, et al.
Bone Marrow Transplantation|February 1, 2020
Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemiaKlaus Wethmar, Svenja Matern, Eva Eßeling, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2021
Dose escalation and expansion phase I studies with the tumour-targeting antibody-tumour necrosis factor fusion protein L19TNF plus doxorubicin in patients with advanced tumours, including sarcomasChristoph Schliemann, Teresa Hemmerle, Andrew F Berdel, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancerLars Henning Schmidt, Janine Stucke-Ring, Caroline Brand, et al.
Lancet (London, England)|July 21, 2024
Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trialsRobert Bissonnette, Richard B Warren, Andreas Pinter, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 16, 2026
S2k guideline occupational skin products: skin protection creams, skin cleansing and skin care productsMichal Gina, Manigé Fartasch, Andrea Bauer, et al.
Plos One|May 23, 2018
Adjuvant chemotherapy-Radiotherapy-Chemotherapy sandwich protocol in resectable soft tissue sarcoma: An updated single-center analysis of 104 casesChristoph Schliemann, Andrea Kerkhoff, Paula Hesse, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 13, 2022
SS18-SSX drives CREB activation in synovial sarcomaMagdalene Cyra, Miriam Schulte, Ruth Berthold, et al.
Pageof 43

Showing results (331-340 of 427) with videos related to

Sort By:
Pageof 43
Oncology Letters|October 8, 2014
Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosisMichael Mohr, Christoph Schliemann, Christoph Biermann, et al.
The European Respiratory Journal|June 2, 2018
Reptin drives tumour progression and resistance to chemotherapy in nonsmall cell lung cancerJan-Henrik Mikesch, Daniela Schwammbach, Wolfgang Hartmann, et al.
Journal of Medicinal Chemistry|March 19, 2013
Anticancer therapy by tumor vessel infarction with polyethylene glycol conjugated retargeted tissue factorChristian Schwöppe, Caroline Zerbst, Max Fröhlich, et al.
Bone Marrow Transplantation|February 1, 2020
Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemiaKlaus Wethmar, Svenja Matern, Eva Eßeling, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2021
Dose escalation and expansion phase I studies with the tumour-targeting antibody-tumour necrosis factor fusion protein L19TNF plus doxorubicin in patients with advanced tumours, including sarcomasChristoph Schliemann, Teresa Hemmerle, Andrew F Berdel, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancerLars Henning Schmidt, Janine Stucke-Ring, Caroline Brand, et al.
Lancet (London, England)|July 21, 2024
Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trialsRobert Bissonnette, Richard B Warren, Andreas Pinter, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 16, 2026
S2k guideline occupational skin products: skin protection creams, skin cleansing and skin care productsMichal Gina, Manigé Fartasch, Andrea Bauer, et al.
Plos One|May 23, 2018
Adjuvant chemotherapy-Radiotherapy-Chemotherapy sandwich protocol in resectable soft tissue sarcoma: An updated single-center analysis of 104 casesChristoph Schliemann, Andrea Kerkhoff, Paula Hesse, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 13, 2022
SS18-SSX drives CREB activation in synovial sarcomaMagdalene Cyra, Miriam Schulte, Ruth Berthold, et al.
Pageof 43